P2RX2 (Purinergic Receptor P2X Ligand-Gated Ion Channel 2) encodes the P2X2 receptor, an ATP-gated ion channel that plays important roles in neuronal signaling, sensory transduction, and neuromuscular transmission. P2X receptors are a family of ligand-gated ion channels that respond to extracellular ATP, making them key sensors of cellular stress and activity. In the nervous system, P2RX2 is expressed in various brain regions and contributes to synaptic transmission, auditory function, and autonomic regulation. Dysregulated P2X2 signaling has been implicated in neuropathic pain, epilepsy, and neurodegenerative diseases.
.infobox.infix-gene
; Gene Symbol
: P2RX2
; Full Name
: Purinergic Receptor P2X Ligand-Gated Ion Channel 2
; Chromosomal Location
: 12q24.31
; NCBI Gene ID
: 22998
; OMIM
: 607228
; Ensembl ID
: ENSG00000171867
; UniProt ID
: Q9UBL9
; Associated Diseases
: Neuropathic Pain, Epilepsy, Deafness, Autonomic Dysfunction, Parkinson's Disease
The P2RX2 gene encodes the P2X2 subunit, one of seven subunits (P2X1-7) that form ATP-gated non-selective cation channels. P2X2 receptors can form homomeric channels (composed of three P2X2 subunits) or heteromeric channels with other P2X subunits.
P2X2 receptors are uniquely characterized by their:
Slow desensitization: P2X2 receptors desensitize slowly compared to other P2X subunits, allowing prolonged ATP responses
Dual gating: Can be activated by low concentrations of ATP and also by acidic pH
Wide tissue distribution: Expressed in neurons, glial cells, and various peripheral tissues
In the brain, P2X2 receptors are involved in modulating synaptic transmission, particularly at glutamatergic and GABAergic synapses[1].
The P2X2 protein:
Topology: Two transmembrane domains (TM1 and TM2), with extracellular loop containing ATP binding site
Subunit composition: Forms trimers (either homomeric P2X2 or heteromeric P2X2/3, P2X2/5, P2X2/6)
Permeability: Permeable to Na+, K+, and Ca2+ (with significant calcium influx)
Desensitization kinetics: Slow desensitization (~300-500 ms to peak, recovery ~1-2 seconds)
Neuromodulation: P2X2 receptors respond to synaptically released ATP, modulating neurotransmitter release[2]
Co-transmission: ATP is co-released with classical neurotransmitters (glutamate, GABA, acetylcholine)
Calcium signaling: Ca2+ influx through P2X2 activates intracellular signaling cascades
Auditory system: Critical for hair cell synaptic transmission in the cochlea[3]
Taste buds: Expressed in taste receptor cells
Baroreception: Involved in blood pressure sensing
Astrocyte signaling: P2X2 on astrocytes responds to neuronal ATP release
Microglial activation: Modulates microglial process motility and cytokine release
Basal ganglia signaling: P2X2 receptors in the striatum modulate GABAergic transmission[4]
Dopaminergic neuron survival: May have neuroprotective effects in the substantia nigra
Therapeutic potential: P2X2 modulators may benefit PD patients
Seizure initiation: P2X2 receptor dysfunction may contribute to hyperexcitability
Astrocyte involvement: Dysregulated ATP signaling through P2X2 contributes to astrocyte-mediated seizure spread
Therapeutic target: P2X2 antagonists have anti-epileptic potential
Sensory neuron signaling: P2RX2 in dorsal root ganglion neurons mediates neuropathic pain
Spinal cord modulation: P2X2 in the dorsal horn contributes to central sensitization
Therapeutic target: P2X2 antagonists are being developed for pain management
P2RX2 mutations cause autosomal recessive deafness (DFNA41), highlighting its critical role in auditory function.
P2RX2 is expressed in:
Hippocampus: CA1-CA3 pyramidal neurons, dentate gyrus
Cortex: Layer 2-6 neurons
Cochlea: Inner hair cells, ribbon synapses
Dorsal root ganglion: Sensory neurons
Spinal cord: Dorsal horn neurons
Autonomic ganglia: Peripheral nervous system
P2X2 receptor structure and function. Nat Rev Neurosci. 2009[1]
P2X2 in synaptic transmission. J Neurosci. 2008[2]
P2X2 in auditory function. Nature. 2006[3]
P2X2 in basal ganglia. Brain Res. 2012[4]
The study of P2Rx2 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.